Lunai Bioworks (LNAI) Profit After Tax (2011 - 2026)
Lunai Bioworks (LNAI) posted quarterly Profit After Tax of -$2.6 million for Q1 2026, down 1459.26% year-over-year from $189176.0 in Q1 2025, and down 42.9% quarter-over-quarter from -$1.8 million in Q4 2025.
Lunai Bioworks (LNAI) Profit After Tax (2011 - 2026) Analysis & Trends
Lunai Bioworks' Profit After Tax history runs 16 years deep, the most recent figure standing at -$2.6 million for Q1 2026.
- In Q1 2026, Profit After Tax fell 1459.26% year-over-year to -$2.6 million; the TTM figure through Mar 2026 stood at -$128.3 million (down 91.45% YoY), while the FY2025 annual figure was -$178.0 million, down 101.31% from the prior year.
- Profit After Tax for Q1 2026 stood at -$2.6 million, down from -$1.8 million in the prior quarter.
- The five-year high for Profit After Tax was $2.8 million in Q3 2025, with the low at -$126.7 million in Q2 2025.
- The 5-year median for Profit After Tax is -$7.3 million (2024), against an average of -$23.8 million.
- The sharpest annual moves came in 2025 and 2026: Profit After Tax jumped 106.38% in 2025, then sank 1459.26% in 2026.
- Lunai Bioworks' Profit After Tax stood at -$4.5 million in 2022, then slipped by 1.6% to -$4.5 million in 2023, then tumbled by 60.13% to -$7.3 million in 2024, then surged by 75.19% to -$1.8 million in 2025, then tumbled by 42.9% to -$2.6 million in 2026.
- Business Quant data shows LNAI's Profit After Tax at -$2.6 million in Q1 2026, -$1.8 million in Q4 2025, and $2.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Lunai Bioworks | 6.87 Mn | 3.72 Mn | 20,942.00 | -2.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.57 Mn |
| Dec 31, 2025 | -1.80 Mn |
| Sep 30, 2025 | 2.82 Mn |
| Jun 30, 2025 | -126.73 Mn |
| Mar 31, 2025 | 189,176.00 |
| Dec 31, 2024 | -7.25 Mn |
| Sep 30, 2024 | -44.21 Mn |
| Jun 30, 2024 | -15.73 Mn |
| Mar 31, 2024 | -58.99 Mn |
| Dec 31, 2023 | -4.53 Mn |
| Sep 30, 2023 | -9.18 Mn |
| Jun 30, 2023 | -23.20 Mn |
| Mar 31, 2023 | -4.33 Mn |
| Dec 31, 2022 | -4.46 Mn |
| Sep 30, 2022 | -7.70 Mn |
| Jun 30, 2022 | -90.26 Mn |
| Mar 31, 2022 | -6.20 Mn |
| Dec 31, 2021 | -6.58 Mn |
| Sep 30, 2021 | -10.41 Mn |
| Jun 30, 2021 | -17.36 Mn |